Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.

BACKGROUND Neuromyelitis optica (NMO)-IgG is a specific autoantibody marker for NMO. It binds selectively to aquaporin 4 (AQP4), which is highly concentrated in astrocytic foot processes at the blood-brain barrier and is not restricted to optic nerve and spinal cord. Although it is conventionally believed that the brain is spared, brain imaging abnormalities are not uncommon in patients with NMO. OBJECTIVE To investigate the location of brain lesions that are distinctive for NMO with respect to the localization of AQP4 in mammalian brain. DESIGN Observational, retrospective case series. SETTING Clinical serologic cohort of patients tested for NMO-IgG for whom brain MRI images were available. PATIENTS We identified 120 patients seropositive for NMO-IgG for whom brain magnetic resonance images were available. MAIN OUTCOME MEASURE Magnetic resonance imaging abnormalities. RESULTS In 8 patients we observed recurring and distinctive magnetic resonance imaging abnormalities in the hypothalamic and periventricular areas that corresponded to brain regions of high AQP4 expression. CONCLUSION The distribution of NMO-characteristic brain lesions corresponds to sites of high AQP4 expression.

[1]  B. Weinshenker,et al.  Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.

[2]  S. Vukusic,et al.  Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis , 2006, Annals of neurology.

[3]  B. Weinshenker,et al.  Brain abnormalities in neuromyelitis optica. , 2006, Archives of neurology.

[4]  A. Bar-Or,et al.  Neuromyelitis optica with hypothalamic involvement , 2005, Multiple sclerosis.

[5]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[6]  E. Waubant,et al.  An open label study of the effects of rituximab in neuromyelitis optica , 2005, Neurology.

[7]  B. Nico,et al.  The role of aquaporin-4 in the blood–brain barrier development and integrity: Studies in animal and cell culture models , 2004, Neuroscience.

[8]  G. Manley,et al.  Expression of aquaporin water channels in mouse spinal cord , 2004, Neuroscience.

[9]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[10]  Ole P. Ottersen,et al.  The molecular basis of water transport in the brain , 2003, Nature Reviews Neuroscience.

[11]  Kenji Ikeda,et al.  Enhanced expression of aquaporin 4 in human brain with infarction , 2003, Acta Neuropathologica.

[12]  Hans Lassmann,et al.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. , 2002, Brain : a journal of neurology.

[13]  B. Weinshenker,et al.  Plasma exchange for severe attacks of CNS demyelination: Predictors of response , 2002, Neurology.

[14]  P C O'Brien,et al.  The clinical course of neuromyelitis optica (Devic’s syndrome) , 1999, Neurology.

[15]  J. Cano,et al.  Detailed localization of aquaporin-4 messenger RNA in the CNS: preferential expression in periventricular organs , 1999, Neuroscience.

[16]  P. Agre,et al.  Specialized Membrane Domains for Water Transport in Glial Cells: High-Resolution Immunogold Cytochemistry of Aquaporin-4 in Rat Brain , 1997, The Journal of Neuroscience.

[17]  P. Cabre,et al.  Recurrent Optic Neuromyelitis with Endocrinopathies , 1997, Neurology.

[18]  C. Turck,et al.  Immunolocalization of the mercurial-insensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Baraban,et al.  Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.